Meanwhile, drugs with thrombolytic therapeutic effect, e.g. urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA) may be potential treatment for obstructive hydrocephalus, partially validated by Gaberel et al. [201]. Here, PLAU is linked to obstructive hydrocephalus.